Concepedia

Rosa Lapalombella

RL

59

Publications

3.6K

Citations

33

H-Index

2002

Active since

Affiliations

The Ohio State University(Current)

University of Bologna

Medicina

The University of Texas MD Anderson Cancer Center

Karyopharm Therapeutics (United States)

Rosa Lapalombella is an author at The Ohio State University specializing in medicine, immunology, and cell biology.

ORCID

Top concepts

Publications per year

2002–2024

59

Publications

59

Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia

Rosa Lapalombella, Qingxiang Sun, Katie Williams et al. · Blood · 2012 · 293 citations · Full text

Genetic Validation of the Protein Arginine Methyltransferase PRMT5 as a Candidate Therapeutic Target in Glioblastoma

Fengting Yan, Lapo Alinari, Mark Lustberg et al. · Cancer Research · 2014 · 182 citations · Full text

The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation

Sean D. Reiff, Rose Mantel, Lisa L. Smith et al. · Cancer Discovery · 2018 · 161 citations · Full text

Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation

Lapo Alinari, Kiran V. Mahasenan, Fengting Yan et al. · Blood · 2015 · 143 citations · Full text

Higher Doses of Lenalidomide Are Associated With Unacceptable Toxicity Including Life-Threatening Tumor Flare in Patients With Chronic Lymphocytic Leukemia

Leslie A. Andritsos, Amy J. Johnson, Gerard Lozanski et al. · Journal of Clinical Oncology · 2008 · 141 citations · Full text

Rows per page

1–5 of 59